FDA approves new streamlined workflow option for Roche’s cobas HPV Test – MarketWatch

FDA approves new streamlined workflow option for Roche's cobas HPV Test
MarketWatch
INDIANAPOLIS, June 26, 2013 /PRNewswire via COMTEX/ — Roche (six:RO)(six:ROG)(otcqx:RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved a new, more efficient workflow process for the cobas HPV Test, allowing 
FDA Approves New Workflow Option for Roche's Cobas HPV TestGenomeWeb

all 3 news articles »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *